Sign up to save your podcasts
Or
Share Alleviate with ZERVIATEandtrade; andndash; First New Molecule for Allergic Conjunctivitis in Over 10 Years! (Advancing Ocular Health)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Alleviate with ZERVIATEandtrade; andndash; First New Molecule for Allergic Conjunctivitis in Over 10 Years! (Advancing Ocular Health)
In the first installment, Ranjan P. Malhotra, MD, FACS, and Eric T. Brooker, OD, FAAO, discuss safety and phase 3 data of ZERVIATE™, the first topical ocular formulation of cetirizine. ZERVIATE™ formulated with Hydrella is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
View all episodes
In the first installment, Ranjan P. Malhotra, MD, FACS, and Eric T. Brooker, OD, FAAO, discuss safety and phase 3 data of ZERVIATE™, the first topical ocular formulation of cetirizine. ZERVIATE™ formulated with Hydrella is indicated for the treatment of ocular itching associated with allergic conjunctivitis.